dc.contributor.author |
Horvath, Ulrike E.I.
|
|
dc.contributor.author |
Dobrzanska, Liliana
|
|
dc.contributor.author |
Strasser, Christoph E.
|
|
dc.contributor.author |
Bouwer, Wilna
|
|
dc.contributor.author |
Joone, Gisela Käthe
|
|
dc.contributor.author |
Jansen van Rensburg, Constance Elizabeth
|
|
dc.contributor.author |
Cronje, Stephanie
|
|
dc.contributor.author |
Raubenheimer, Helgard G.
|
|
dc.date.accessioned |
2012-05-23T08:31:48Z |
|
dc.date.available |
2012-05-23T08:31:48Z |
|
dc.date.issued |
2012-06 |
|
dc.description.abstract |
A series of new neutral mononuclear or dinuclear gold(I) complexes and a cyclic cationic
tetranuclear amidogold(I) complex comprising of the phosphines 1,2-
bis(dimethylphosphino)ethane (dmpe), μ-1,2–bis(diphenylphosphino)ethane (dppe), μ-1,3-
bis(diphenylphosphino)propane (dppp), μ-1,5-bis(diphenylphosphino)pentane (dpppe), μ-1,6-
bis(diphenylphosphino)hexane (dpph) or trimethylphosphine, and several N-heterocyclic ring
systems (imidazolate, pyrazolate, 1,2,3-triazolate, 1,2,4-triazolate, pyrrolate, 9H-purine-9-ate or
9H-purine-6-amine-9-ate) as ligands, reveal intermolecular aurophilic interactions and 2D
channels available for solvent molecules in some of their crystal structures. The antitumour activity of the acyclic gold(I) compounds is highly dependent on the substituents on the
phosphorus atoms being highest for phenyl groups and lower for methyl groups. The activity of
these compounds against selected cell lines is linked to the length of the carbon bridge between
the two phosphorus atoms being highest with a bridge consisting of 5 or 6 carbons. Two
compounds with the highest tumour specifities that contain dpppe and pyrazolate (a lipophilic
compound) or 1,2,4-triazolate (a hydrophilic compound) induce the apoptic cell death pathway
and tolerate a maximum dose of 1.5 μmol/kg when administered to Balb/C mice. |
en_US |
dc.description.sponsorship |
Claude Harris Leon Foundation (UEIH), Alexander von Humboldt Stiftung
(HGR and SC), NRF (National Research Foundation, South Africa), Harmony Gold Mining Co. Ltd.through Project Autek and the Research Foundation Flanders – FWO (LD) |
en_US |
dc.description.uri |
http:// www.sciencedirect.com/science/journal/01620134 |
en_US |
dc.identifier.citation |
Ulrike E.I. Horvath, Liliana Dobrzańska, Christoph E. Strasser, Wilna Bouwer, Gisela Joone, Constance E. Jansen van Rensburg, Stephanie Cronje & Helgard G. Raubenheimer, Amides of gold(I) diphosphines prepared from N-heterocyclic sources and their in vitro and in vivo screening for anticancer activity, Journal of Inorganic Biochemistry, vol. 111, no. 6, pp. 80-90 (2012), doi: 10.1016/j.jinorgbio.2012.02.026 |
en_US |
dc.identifier.issn |
0162-0134 (print) |
|
dc.identifier.issn |
1872-3344 (online) |
|
dc.identifier.other |
10.1016/j.jinorgbio.2012.02.026 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/18841 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Elsevier |
en_US |
dc.rights |
© 2012 Elsevier Inc. All rights reserved. |
en_US |
dc.subject |
Azolate |
en_US |
dc.subject |
Purine-ate |
en_US |
dc.subject |
Gold(I) diphosphines |
en_US |
dc.subject |
Cytotoxicity |
en_US |
dc.subject |
Pyrazolate |
en_US |
dc.subject |
Anti-tumour |
en_US |
dc.title |
Amides of gold(I) diphosphines prepared from N-heterocyclic sources and their in vitro and in vivo screening for anticancer activity |
en_US |
dc.type |
Postprint Article |
en_US |